Actinium Pharmaceuticals Inc (ATNM) — Cash Flow Reinvestment Rate
Actinium Pharmaceuticals Inc (ATNM) has a Cash Flow Reinvestment Rate of 0.02x as of June 2022, reinvesting $540.00K (capex $270.00K plus investments $-270.00K) from operating cash flow of $27.92 Million. Explore Actinium Pharmaceuticals Inc (ATNM) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Actinium Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Actinium Pharmaceuticals Inc across 3 annual periods. Also explore Actinium Pharmaceuticals Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Actinium Pharmaceuticals Inc (2010–2022)
Year-by-year capital reinvestment analysis for Actinium Pharmaceuticals Inc. For live market cap and broader valuation context, see Actinium Pharmaceuticals Inc (ATNM) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.08x | $732.00K | $8.64 Million | $366.00K | — |
| 2011 | 0.00x | $0.00 | $539.00 | $0.00 | — |
| 2010 | 0.00x | $0.00 | $7.83K | $0.00 | — |